SCHEMBL13840696

SCHEMBL13840696

CC(C)(Cc1cccc(C(=O)NCCc2ccc(Cl)cc2)c1)NC[C@H](O)c1cc(O)cc(O)c1

nearest known ligand 0.47

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ NPC1 O15118 4/20 0.47
▸ RAB9A P51151 4/20 0.47
▸ MAPT P10636 2/20 0.47
▸ SMN1; SMN2 Q16637 2/20 0.47
▸ CYP1A2 P05177 1/20 0.47
▸ GAA P10253 1/20 0.47
▸ CYP2D6 P10635 1/20 0.47
▸ CYP2C19 P33261 1/20 0.47
▸ GFER P55789 1/20 0.47
▸ PARP1 P09874 1/20 0.45
▸ ADRB2 P07550 7/20 0.44
▸ ADRB1 P08588 3/20 0.42
▸ ALDH1A1 P00352 1/20 0.42
▸ FABP2 P12104 1/20 0.42
▸ PPARG P37231 1/20 0.42
▸ PPARD Q03181 1/20 0.42
▸ PPARA Q07869 1/20 0.42
▸ MCHR1 Q99705 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3917066 1.00 NPC1 (0.47) NPC1RAB9AMAPTSMN1; SMN2CYP1A2
SCHEMBL13840715 0.92 ADRB2 (0.49) NPC1RAB9AMAPTSMN1; SMN2CYP1A2
SCHEMBL3924003 0.92 ADRB2 (0.49) NPC1RAB9AMAPTSMN1; SMN2CYP1A2
SCHEMBL13840706 0.87 PARP1 (0.46) MAPTPARP1ADRB2ADRB1
SCHEMBL3914423 0.87 PARP1 (0.46) MAPTPARP1ADRB2ADRB1
SCHEMBL3924678 0.87 PARP1 (0.44) NPC1RAB9AGAAPARP1ADRB2
SCHEMBL13840701 0.87 PARP1 (0.44) NPC1RAB9AGAAPARP1ADRB2
SCHEMBL13840733 0.87 ADRB2 (0.55) SMN1; SMN2ADRB2ALDH1A1
SCHEMBL3915467 0.87 ADRB2 (0.55) SMN1; SMN2ADRB2ALDH1A1
SCHEMBL4388116 0.86 ADRB2 (0.61) CYP1A2CYP2D6ADRB2ADRB1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1730141-B1 COMPOUNDS FOR THE TREATMENT OF DISEASES PFIZER LTD (GB) 2009-05-27 — — EP disclosed
US-7538141-B2 Compounds for the treatment of diseases PFIZER INC. 2009-05-26 — — US disclosed
US-7538141-B2 Compounds for the treatment of diseases PFIZER INC. 2009-05-26 — — US disclosed
Send feedback